tradingkey.logo
tradingkey.logo
Search

Sinovac Biotech Ltd

SVA
Add to Watchlist
0.000USD
0.0000.00%
Close 12-22 16:00ET
0.00Market Cap
0.00P/E TTM

About Sinovac Biotech Ltd Company

Sinovac Biotech Ltd (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, hand foot and mouth disease (HFMD), seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps. The Company's pipeline consists of vaccine candidates in the clinical and pre-clinical development Phases in China. The Company is engaged in the sales, marketing, manufacturing and development of vaccines for infectious disease. The Company develops various products, including Healive, Bilive, Anflu, Panflu Whole Viron Pandemic Influenza Vaccine, Split Viron Pandemic Influenza Vaccine, Panflu.1, Mumps Vaccine, Enterovirus 71 (EV71) Vaccine, Pneumococcal Polysaccharide Vaccine, Pneumococcal Conjugate Vaccine.

Sinovac Biotech Ltd Profile

Ticker SymbolSVA
Company nameSinovac Biotech Ltd
IPO dateNov 13, 2009
CEOYin (Weidong)
Number of employees3037
Security typeOrdinary Share
Fiscal year-endNov 13
AddressNo. 39 Shangdi Xi Road
CityBEIJING
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryChina
Postal code100085
Phone861082890088
Websitehttp://www.sinovac.com/
Ticker SymbolSVA
IPO dateNov 13, 2009
CEOYin (Weidong)

Company Executives of Sinovac Biotech Ltd

Name
Name/Position
Position
Shareholding
Change
Dr. Chiang Li
Dr. Chiang Li
Independent Director
Independent Director
18.52M
--
Dr. Chiang Li
Dr. Chiang Li
Independent Director
Independent Director
18.52M
--
Mr. Weidong Yin
Mr. Weidong Yin
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
6.36M
--
Mr. Weidong Yin
Mr. Weidong Yin
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
6.36M
--
Mr. Simon J. Anderson
Mr. Simon J. Anderson
Independent Director
Independent Director
--
--
Prof. Lam Lo Yuk
Prof. Lam Lo Yuk
Independent Director
Independent Director
--
--
Ms. Wang Nan
Ms. Wang Nan
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
--
--
Mr. Fu Shan
Mr. Fu Shan
Independent Director
Independent Director
--
--
Mr. Gao Qiang
Mr. Gao Qiang
Chief Operating Officer, Vice President
Chief Operating Officer, Vice President
--
--
Ms. Li Jing
Ms. Li Jing
Vice President - Quality and Production
Vice President - Quality and Production
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Chiang Li
Dr. Chiang Li
Independent Director
Independent Director
18.52M
--
Dr. Chiang Li
Dr. Chiang Li
Independent Director
Independent Director
18.52M
--
Mr. Weidong Yin
Mr. Weidong Yin
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
6.36M
--
Mr. Weidong Yin
Mr. Weidong Yin
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
6.36M
--
Mr. Simon J. Anderson
Mr. Simon J. Anderson
Independent Director
Independent Director
--
--
Prof. Lam Lo Yuk
Prof. Lam Lo Yuk
Independent Director
Independent Director
--
--

FAQs

Who are the top five shareholders of Sinovac Biotech Ltd?

The top five shareholders of Sinovac Biotech Ltd are: Dr. Chiang Li

How many institutions hold shares of Sinovac Biotech Ltd (SVA)?

As of 2026Q1, 42 institutions hold shares of Sinovac Biotech Ltd, with a combined market value of approximately 21.25M, accounting for 35.39% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -256496.00.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.